Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
ConditionVogt Koyanagi Harada Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-70
SponsorUniversity of Sao Paulo
About this trial
This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.
Eligibility criteria
Qualifiers
None
Disqualifiers
non collaborative patient
minimum one-year follow-up
Trial design
Treatments tested in this trial
- Early high-dose corticosteroid and immunosuppressive therapy
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Sao Paulo
Lead sponsor
Fundação de Amparo à Pesquisa do Estado de São Paulo
Collaborator
Source ClinicalTrials.gov